DICE Therapeutics

DICE designs and develops innovative therapies in immunology for patients with debilitating diseases. By leveraging unique insights using a variety of cutting-edge technologies, DICE combines deep knowledge of target biology and medicinal chemistry to effectively prosecute previously intractable protein-protein interaction and develop novel small molecule therapeutics. With biologics making up the majority of therapeutics for autoimmune diseases, identifying effective small molecule inhibitors can open new therapeutic opportunities for treating debilitating diseases.